188 studies found for:    "ankylosing spondylitis"
Show Display Options
RSS Create an RSS feed from your search for:
"ankylosing spondylitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
2 Unknown  Etanercept (Enbrel) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
3 Unknown  Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: abatacept
4 Completed Remicade in the Treatment of Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Infliximab
5 Completed Study Investigating Enbrel Treatment for Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
6 Unknown  Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: rituximab
7 Completed Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Behavioral: Cardiovascular Training
8 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: adalimumab
9 Completed
Has Results
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
10 Completed
Has Results
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Treatment switching
11 Completed
Has Results
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: sulphasalazine (SSZ)
12 Not yet recruiting A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
13 Completed
Has Results
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
14 Completed Efficacy of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: AIN457;   Drug: ARIN457
15 Unknown  Methotrexate in Ankylosing Spondylitis (MTX in AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: Methotrexate
16 Completed Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: infliximab;   Drug: methotrexate
17 Completed Genetic Determinants of Ankylosing Spondylitis Severity
Condition: Ankylosing Spondylitis
Intervention:
18 Withdrawn A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention: Drug: No intervention
19 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: AIN457A
20 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Etanercept (Enbrel);   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years